2023 Form 5500 filing — Catalyst Pharmaceuticals Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241009171629NAL0019692385001) for Catalyst Pharmaceuticals Inc. 401(K) Plan, reported by Catalyst Pharmaceuticals, Inc. under EIN 76-0837053 and plan number 001. It reports 90 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$11.3MReported net assets$11,300,583
Participants90
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20241009171629NAL0019692385001
Plan sponsor
Catalyst Pharmaceuticals, Inc.
EIN
76-0837053
Plan number
001
Location
Coral Gables, FL
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$11.3M total assets
Net assets$11.3MLiabilities$0
Money in vs. money out
Total income / additions$4.6M
Total expenses$1.2M
Benefits paid / distributions$1.2M
Contributions
Employer$679.9K
Participant$1.7M
Full reported line items
Total assets (EOY)
$11,300,583
Total liabilities (EOY)
$0
Net assets (EOY)
$11,300,583
Employer contributions
$679,874
Participant contributions
$1,650,185
Total income / additions
$4,555,066
Benefits paid
$1,244,517
Administrative expenses
$4,307
Total expenses
$1,248,824
Net increase / (decrease)
$3,306,242

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20241009171629NAL0019692385001 cover?
It is the 2023 Form 5500 filing for Catalyst Pharmaceuticals Inc. 401(K) Plan, reported by Catalyst Pharmaceuticals, Inc. (EIN 76-0837053).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages